Fluvoxamine Attenuated Endoplasmic Reticulum Stress-Induced Leptin Resistance
Open Access
- 1 January 2012
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 3, 11239
Abstract
Increasing evidence indicates that endoplasmic reticulum stress (ER stress) is involved in the development of metabolic syndrome. However, pharmacological treatments targeting ER stress are not well understood. In the present study, we found that fluvoxamine, a selective serotonin reuptake inhibitor used for depression, can attenuate ER stress-induced “leptin resistance,” i.e., insensitivity to the anti-obesity hormone leptin. Treatment with tunicamycin, an ER stress-inducing reagent, caused cell death which was significantly inhibited by fluvoxamine. Leptin activates JAK2–STAT3 signaling. ER stress caused an impairment of leptin-induced STAT3 phosphorylation which was reversed by fluvoxamine. Fluvoxamine would be a novel leptin-sensitizing drug, which targets ER stress.Keywords
This publication has 32 references indexed in Scilit:
- Transient receptor potential channels and vascular functionClinical Science, 2010
- A unique modulator of endoplasmic reticulum stress-signalling pathways: the novel pharmacological properties of amiloride in glial cellsBritish Journal of Pharmacology, 2009
- The pharmacology of sigma-1 receptorsPharmacology & Therapeutics, 2009
- Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin ResistanceCell Metabolism, 2009
- Endoplasmic Reticulum Stress Induces Leptin ResistanceMolecular Pharmacology, 2008
- Hypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and ObesityCell, 2008
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling PathwaysPLOS ONE, 2008
- The leptin hypothesis of depression: a potential link between mood disorders and obesity?Current Opinion in Pharmacology, 2007
- Association Between Obesity and Psychiatric Disorders in the US Adult PopulationArchives of General Psychiatry, 2006
- Molecular and anatomical determinants of central leptin resistanceNature Neuroscience, 2005